EGFR and neoplasm: EGFR expression is frequently elevated in malignant breast cancers, including BLBCs, and such increased expression is thought to contribute to chemoresistance, aggressive growth and expression of tumour initiating ability (Dawood, 2010; Foley et al, 2010; Saxena & Dwivedi, 2012).